Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation.

Piazza, Gregory; Hurwitz, Shelley; Harrigan, Lindsay M; Jenkins, Kathryn L; Hohlfelder, Benjamin; Fanikos, John; Goldhaber, Samuel Z

Piazza, Gregory; Hurwitz, Shelley; Harrigan, Lindsay M; Jenkins, Kathryn L; Hohlfelder, Benjamin; Fanikos, John; Goldhaber, Samuel Z.

Afiliação

Piazza G; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Hurwitz S; Center for Clinical Investigation, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Harrigan LM; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Jenkins KL; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Hohlfelder B; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Fanikos J; Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Goldhaber SZ; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

TH Open ; 2(1): e33-e38, 2018 Jan.

Article em En | MEDLINE | ID: mdl-31249927

Palavras-chave

adverse events; anticoagulation; atrial fibrillation; mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Revista: TH Open Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google